Proteoglycans in host–pathogen interactions: molecular mechanisms and therapeutic implications
- 1 February 2010
- journal article
- review article
- Published by Cambridge University Press (CUP) in Expert Reviews in Molecular Medicine
- Vol. 12, e5
Abstract
Many microbial pathogens subvert proteoglycans for their adhesion to host tissues, invasion of host cells, infection of neighbouring cells, dissemination into the systemic circulation, and evasion of host defence mechanisms. Where studied, specific virulence factors mediate these proteoglycan–pathogen interactions, which are thus thought to affect the onset, progression and outcome of infection. Proteoglycans are composites of glycosaminoglycan (GAG) chains attached covalently to specific core proteins. Proteoglycans are expressed ubiquitously on the cell surface, in intracellular compartments, and in the extracellular matrix. GAGs mediate the majority of ligand-binding activities of proteoglycans, and many microbial pathogens elaborate cell-surface and secreted factors that interact with GAGs. Some pathogens also modulate the expression and function of proteoglycans through known virulence factors. Several GAG-binding pathogens can no longer attach to and invade host cells whose GAG expression has been reduced by mutagenesis or enzymatic treatment. Furthermore, GAG antagonists have been shown to inhibit microbial attachment and host cell entry in vitro and reduce virulence in vivo. Together, these observations underscore the biological significance of proteoglycan–pathogen interactions in infectious diseases.Keywords
This publication has 195 references indexed in Scilit:
- Investigating the Elusive Mechanism of Glycosaminoglycan BiosynthesisJournal of Biological Chemistry, 2009
- Helicobacter pylori in Health and DiseaseGastroenterology, 2009
- AMPed up immunity: how antimicrobial peptides have multiple roles in immune defenseTrends in Immunology, 2009
- Surfen, a small molecule antagonist of heparan sulfateProceedings of the National Academy of Sciences, 2008
- Using a 3-O-Sulfated Heparin Octasaccharide To Inhibit the Entry of Herpes Simplex Virus Type 1Biochemistry, 2008
- Syndecan-3 is a dendritic cell-specific attachment receptor for HIV-1Proceedings of the National Academy of Sciences, 2007
- Hepatitis B virus infection initiates with a large surface protein–dependent binding to heparan sulfate proteoglycansHepatology, 2007
- Heparan Sulfate Proteoglycans Provide a Signal to Plasmodium Sporozoites to Stop Migrating and Productively Invade Host CellsCell Host & Microbe, 2007
- Parameters of inhibition of HIV-1 infection by small anionic microbicidesAntiviral Research, 2007
- Ligand-induced and nonfusogenic dissolution of a viral membraneProceedings of the National Academy of Sciences, 2006